ARTICLE | Clinical News
HIRMAb-IDUA regulatory update
November 16, 2015 8:00 AM UTC
FDA granted rare pediatric disease designation to AGT-181 from ArmaGen to treat mucopolysaccharidosis I (MPS I, Hurler syndrome). AGT-181 is in Phase I/IIa testing for MPS I. The product is alpha-L-i...